Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SILIUS: Sorafenib + Low-dose FP HAIC in Advanced HCC
NCT00933816Phase 2Completed
- Sponsor
- Kindai University
- Start
- Jul 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib, cisplatin, fluorouracil in hepatocellular carcinoma (HCC), sponsored by Kindai University. Started Jul 2009; status: completed.
02
Drugs
sorafenibcisplatinfluorouracil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00933816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00933816.